Interactive Transcript
0:00
So challenge number 13.
0:01
This is a patient who, on her diagnostic study,
0:05
here's the post GAD image and here is the subtraction image.
0:09
So she had clumped linear enhancement.
0:12
So this is pretty concerning for non mass enhancement.
0:15
You know, you're, you're pretty worried that's going to be,
0:17
um, DCIS.
0:19
Here's her post biopsy MR Study.
0:23
You can see she's got air in the cavity here, a little bit
0:26
of hemorrhage or fluid up here.
0:28
And it looks like the sampling was
0:30
really, you know, pretty good.
0:31
It looks like it was in the right place,
0:33
and yet this came back as being fibrocystic change.
0:36
So the question is, is it a non concordant biopsy or not?
0:41
Um, when they've done studies, there's actually some kind
0:44
of frightening figures out there for guided biopsies
0:46
and they have shown that, uh, up to 15%, 14% of lesions
0:51
that are targeted are inadequately sampled.
0:53
If you do a follow-up gadolinium enhanced MR study,
0:56
and this has come from a couple of studies,
0:58
so in other words, you think you've got it,
1:00
you're completely happy with it, you think it's concordant,
1:03
you do a follow-up study and no, you haven't,
1:04
whether it's benign or malignant.
1:06
And overall the amount of false negative
1:09
MR guided biopsies is 2.5%, which is significantly higher
1:14
than it is for stereo tactical and ultrasound guided biopsy.
1:19
So if you get a result
1:20
that you are concerned may be discordant
1:22
and you do the same rad path correlation you do with,
1:25
you know, anything else that we biopsy, any other way
1:27
that we biopsy in breast imaging, the first thing you want
1:30
to do is check the adequacy of your biopsy.
1:32
So look back, look at where the cavity was compared to your,
1:37
um, prebi gadolinium enhanced study.
1:40
Look at where the clip is on the post mammogram
1:43
and then depending on how concerned about it,
1:46
you could do a couple of different things.
1:47
You could do a short interval follow up
1:49
and I wouldn't really wait six to months
1:52
unless you have very low concern about this lesion.
1:56
I think six to eight weeks is the
1:57
more appropriate follow up.
1:59
You can then take them back
2:00
and re-biopsy them if, um, you see
2:03
that the lesion is still there
2:05
and you could set them up for a, um,
2:07
diagnostic slash biopsy slots, you already
2:10
to go in one go if you wish.
2:12
At that point, um, you could take them back
2:15
and do an MR guided needle lo at the lesion,
2:18
or you could do a regular mammographic needle lo using
2:21
the clip placed in biopsy.
2:23
If you consider that that is in the right position
2:25
and probably getting the surgeon to be reasonably generous
2:28
with their biopsies.